Literature DB >> 10924587

Early-stage rheumatoid arthritis: prospective study of the effectiveness of MR imaging for diagnosis.

H Sugimoto1, A Takeda, K Hyodoh.   

Abstract

PURPOSE: To assess the effectiveness of magnetic resonance (MR) imaging for the diagnosis of early-stage rheumatoid arthritis (RA).
MATERIALS AND METHODS: Fifty subjects (nine men and 41 women) with polyarthralgia who were suspected of having early-stage RA on the basis of clinical and radiographic findings were selected to undergo gadolinium-enhanced MR imaging of the hands. The MR imaging criterion for the diagnosis of early RA was bilateral enhancement in both wrists and/or the metacarpophalangeal and/or proximal interphalangeal joints. Follow-up continued until a final diagnosis was determined. Two patients left the study before the end of follow-up.
RESULTS: Final diagnoses were established after a mean follow-up of 776 days: rheumatoid arthritis in 26 patients and nonrheumatoid disease in 22. Use of the MR imaging criterion yielded the correct diagnosis in 25 patients with RA and three false-positive results in three patients without RA. As compared with the traditional format and classification tree criteria of the American Rheumatism Association, the MR imaging criterion allowed detection of seven and six additional patients with true RA, respectively.
CONCLUSION: The introduction of MR imaging into the diagnostic criteria for early RA may contribute to more accurate diagnosis in patients suspected of having RA and thus allow an earlier decision to start proper medication.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10924587     DOI: 10.1148/radiology.216.2.r00au20569

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  35 in total

Review 1.  Imaging of the hand and wrist in RA.

Authors:  B Taouli; A Guermazi; K E Sack; H K Genant
Journal:  Ann Rheum Dis       Date:  2002-10       Impact factor: 19.103

2.  Rheumatoid Arthritis: Early diagnosis and treatment outcomes.

Authors:  Behzad Heidari
Journal:  Caspian J Intern Med       Date:  2011

3.  EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

Authors:  B Combe; R Landewe; C Lukas; H D Bolosiu; F Breedveld; M Dougados; P Emery; G Ferraccioli; J M W Hazes; L Klareskog; K Machold; E Martin-Mola; H Nielsen; A Silman; J Smolen; H Yazici
Journal:  Ann Rheum Dis       Date:  2006-01-05       Impact factor: 19.103

Review 4.  Ultrasonography and magnetic resonance imaging in early rheumatoid arthritis: recent advances.

Authors:  Mikkel Østergaard; Uffe M Døhn; Bo J Ejbjerg; Fiona M McQueen
Journal:  Curr Rheumatol Rep       Date:  2006-10       Impact factor: 4.592

Review 5.  [Macrophage specific MRI imaging for antigen induced arthritides. A potential new strategy for the diagnosis of rheumatoid arthritis].

Authors:  G H Simon; H E Daldrup-Link; E J Rummeny
Journal:  Radiologe       Date:  2007-01       Impact factor: 0.635

Review 6.  [Early diagnosis of rheumatoid arthritis].

Authors:  M Schneider; B Ostendorf; C H Specker
Journal:  Z Rheumatol       Date:  2005-11       Impact factor: 1.372

Review 7.  Arthroscopic synovectomy in rheumatoid arthritis of wrist.

Authors:  Sung-Jae Kim; Kwang-Am Jung
Journal:  Clin Med Res       Date:  2007-12-17

Review 8.  Emerging MRI methods in rheumatoid arthritis.

Authors:  Camilo G Borrero; James M Mountz; John D Mountz
Journal:  Nat Rev Rheumatol       Date:  2010-11-02       Impact factor: 20.543

9.  MRI characteristics of rheumatoid arthritis in the temporomandibular joint.

Authors:  K Kretapirom; K Okochi; S Nakamura; A Tetsumura; N Ohbayashi; N Yoshino; T Kurabayashi
Journal:  Dentomaxillofac Radiol       Date:  2012-07-27       Impact factor: 2.419

10.  Inflammatory arthritis-like and other MR findings in wrists of asymptomatic subjects.

Authors:  P L Robertson; P J Page; G J McColl
Journal:  Skeletal Radiol       Date:  2006-03-14       Impact factor: 2.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.